Private company
Third Rock Ventures III, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Third Rock Ventures III, L.P. sits at the top of its group. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Third Rock Ventures III, L.P. DE
- Decibel Therapeutics, Inc. Stake · Boston, Massachusetts
- Fulcrum Therapeutics (United States) Stake · Cambridge, Massachusetts
- Nurix (United States) Stake · Brisbane, California
- Pliant (United States) Stake · South San Francisco, California
- Relay Therapeutics Stake · Cambridge, Massachusetts
- Revolution Medicines (United States) Stake · Redwood City, California, United States
- Voyager Therapeutics (United States) Stake · Cambridge
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.
Stakes it holds
Third Rock Ventures III, L.P. has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).
- Fulcrum Therapeutics (United States)SC 13G/A Feb 14, 2022 to Feb 14, 20242
- Pliant (United States)SC 13G/A Feb 14, 2023 to Feb 14, 20243
- Voyager Therapeutics (United States)SC 13G/A Feb 14, 2023 to Feb 14, 20244
- Nurix (United States)SC 13G/A Feb 14, 2022 to Feb 14, 20235
- Revolution Medicines (United States)SC 13G/A Feb 14, 2022 to Feb 14, 20236
- Decibel Therapeutics, Inc.SC 13G Feb 14, 20227
- Relay TherapeuticsSC 13G/A Feb 14, 20228
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8